1Calhoun DA,Jones 0, Textor S, et al. Resistant hypertension: Diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research[J]. Hypertension, 2008,51 (6) : 1403-1419.
2Gaddam KK, Nishizaka MK, Pratt-Ubunama MN, et al. Characterization of resistant hypertension: Association between resistant hypertension, aldosterone, and persistent intravascular volume expansion[J]. Arch Intern Med, 2008,168(11): 1159- 1164.
3Smith PA, Graham LN, Mackintosh AF, et al. Relationship between central sympathetic activity and stages of human hypertension[J]. AmJ Hypertens, 2004,17(3) :217-222.
4Grimson KS. Total thoracic and partial to total lumbar sympathectomy and celiac ganglionectomy in the treatment of hypertension[J]. Ann Surg, 1941,114(4):753-775.
5Smithwick RH, ThompsonJE. Splanchnicectomy for essential hypertension; results in 1,266 cases[J].J Am Med Assoc. 1953, 152( 16): 1501-1504.
6Morrissey OM, Brookes VS, Cooke WT. Sympathectomy in the treatment of hypertension; review of 122 eases[J]. Lancet. 1953, I (9) :403-408.
7Doumas M, Douma S. Interventional management of resistant hypertension[J]. Laneet, 2009,373(9671): 1228-1230.
8Grisk 0, Rose H], Lorenz G, et al. Sympathetic-renal interaction in chronic arterial pressure control[J]. AmJ Physiol Regullntegr Comp Physiol, 2002,283(2):R441-R450.
9Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: A multicentre safety and proof-of-principle cohort study[J]. Lancet, 2009, 373( 9671) : 1275-1281.
10Symplicity HTN-I investigators. Catheter-based renal sympathe?tic denervation for resistant hyptersion , Durability of blood pressure reduction out to 24 months[J]. Hypertension, 2011, 57(5) :911-917.
